Literature DB >> 23001096

Tachycardia-induced cardiomyopathy.

Bruno Tsutomu Nakatani1, Marcos Ferreira Minicucci, Katashi Okoshi, Marina Politi Okoshi.   

Abstract

Tachycardia-induced cardiomyopathy (TIC) is an important cause of heart failure as it is potentially reversible after ventricular rate control. A 66-year-old hypertensive woman presented with a 15-day history of tachycardia, dyspnoea and oedema. ECG revealed atrial fibrillation with ventricular frequency of 130 beats per minute (bpm). Echocardiogram showed dilated left ventricle (LV) with 0.39 ejection fraction. Angiography revealed non-obstructed coronary arteries. Heart rate and cardiac failure were controlled with amiodarone, digoxine, captopril, metoprolol and furosemide. During follow-up, despite drug dose optimisation, the patient kept complaining of tachycardia and dyspnoea with a ventricular rate between 108 and 120 bpm. Medical staff suspected she was not taking her medicines properly. Two months later, the patient was asymptomatic and had converted to sinus rhythm (heart rate of 76 bpm). Echocardiogram showed normal LV size and function. Patient's diagnosis was TIC. Although rare, TIC should be considered in all cases of systolic dysfunction associated with tachyarrhythmia.

Entities:  

Mesh:

Year:  2012        PMID: 23001096      PMCID: PMC4543895          DOI: 10.1136/bcr-2012-006587

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

Review 1.  Atrial fibrillation.

Authors:  Gregory Y H Lip; Hung Fat Tse; Deirdre A Lane
Journal:  Lancet       Date:  2011-12-11       Impact factor: 79.321

2.  Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia.

Authors:  W Grimm; V Menz; J Hoffmann; B Maisch
Journal:  Pacing Clin Electrophysiol       Date:  2001-02       Impact factor: 1.976

3.  Reversibility of "tachycardia induced cardiomyopathy" following the cure of idiopathic left ventricular tachycardia using radiofrequency energy.

Authors:  B Singh; U Kaul; K K Talwar; H S Wasir
Journal:  Pacing Clin Electrophysiol       Date:  1996-09       Impact factor: 1.976

4.  First evidence of premature ventricular complex-induced cardiomyopathy: a potentially reversible cause of heart failure.

Authors:  S S Chugh; W K Shen; D M Luria; H C Smith
Journal:  J Cardiovasc Electrophysiol       Date:  2000-03

5.  Tachycardia induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia.

Authors:  I Zupan; P Rakovec; N Budihna; A Brecelj; M Kozelj
Journal:  Int J Cardiol       Date:  1996-09       Impact factor: 4.164

Review 6.  Tachycardia-induced cardiomyopathy: evaluation and therapeutic options.

Authors:  Anton Lishmanov; Priya Chockalingam; Annamalai Senthilkumar; Anand Chockalingam
Journal:  Congest Heart Fail       Date:  2010 May-Jun

7.  Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy.

Authors:  Hiroshi Watanabe; Kazuki Okamura; Masaomi Chinushi; Hiroshi Furushima; Yasutaka Tanabe; Makoto Kodama; Yoshifusa Aizawa
Journal:  Int Heart J       Date:  2008-01       Impact factor: 1.862

8.  Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy.

Authors:  Young-Hoon Jeong; Kee-Joon Choi; Jong-Min Song; Eui-Seock Hwang; Kyoung-Min Park; Gi-Byoung Nam; Jae-Joong Kim; You-Ho Kim
Journal:  Clin Cardiol       Date:  2008-04       Impact factor: 2.882

9.  Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy.

Authors:  Tadashi Fujino; Takeshi Yamashita; Shinya Suzuki; Hiroaki Sugiyma; Koichi Sagara; Hitoshi Sawada; Tadanori Aizawa; Masaki Igarashi; Junichi Yamazaki
Journal:  Circ J       Date:  2007-06       Impact factor: 2.993

10.  Tachycardia-induced heart failure.

Authors:  Jitenbhai J Patel; Charles T Whittaker
Journal:  Perm J       Date:  2007
View more
  1 in total

1.  The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

Authors:  Emil Eik Nielsen; Joshua Feinberg; Ilan Raymond; Michael Hecht Olsen; Frank Victor Steensgaard-Hansen; Janus Christian Jakobsen
Journal:  Syst Rev       Date:  2019-10-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.